1. Home
  2. PED vs ADVM Comparison

PED vs ADVM Comparison

Compare PED & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PED
  • ADVM
  • Stock Information
  • Founded
  • PED N/A
  • ADVM 2006
  • Country
  • PED United States
  • ADVM United States
  • Employees
  • PED N/A
  • ADVM N/A
  • Industry
  • PED Oil & Gas Production
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PED Energy
  • ADVM Health Care
  • Exchange
  • PED Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • PED 48.8M
  • ADVM 47.4M
  • IPO Year
  • PED N/A
  • ADVM 2014
  • Fundamental
  • Price
  • PED $0.64
  • ADVM $2.56
  • Analyst Decision
  • PED Strong Buy
  • ADVM Strong Buy
  • Analyst Count
  • PED 2
  • ADVM 5
  • Target Price
  • PED $1.63
  • ADVM $23.80
  • AVG Volume (30 Days)
  • PED 581.5K
  • ADVM 332.6K
  • Earning Date
  • PED 08-13-2025
  • ADVM 08-11-2025
  • Dividend Yield
  • PED N/A
  • ADVM N/A
  • EPS Growth
  • PED 2248.88
  • ADVM N/A
  • EPS
  • PED 0.19
  • ADVM N/A
  • Revenue
  • PED $40,173,000.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • PED N/A
  • ADVM N/A
  • Revenue Next Year
  • PED $5.99
  • ADVM $18.82
  • P/E Ratio
  • PED $3.27
  • ADVM N/A
  • Revenue Growth
  • PED 30.70
  • ADVM N/A
  • 52 Week Low
  • PED $0.47
  • ADVM $1.78
  • 52 Week High
  • PED $1.10
  • ADVM $10.14
  • Technical
  • Relative Strength Index (RSI)
  • PED 44.05
  • ADVM 52.87
  • Support Level
  • PED $0.58
  • ADVM $2.19
  • Resistance Level
  • PED $0.67
  • ADVM $2.60
  • Average True Range (ATR)
  • PED 0.04
  • ADVM 0.23
  • MACD
  • PED -0.01
  • ADVM 0.02
  • Stochastic Oscillator
  • PED 21.96
  • ADVM 83.52

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: